Theravance Biopharma, Inc. 4

Rhonda Farnum, SVP, Commercial & Medical Affairs of Theravance Biopharma, Inc., had 5,667 ordinary shares withheld by the company at about $16.95 per share to cover taxes on RSU vesting.

On August 20, 2026, Rhonda Farnum, SVP, Commercial & Medical Affairs of Theravance Biopharma, Inc., had 5,667 ordinary shares withheld by the issuer at an implied price of $16.95 per share to cover tax obligations arising from the vesting of previously granted restricted stock units, a non-open-market, administrative transaction that reduced her directly held stake to 226,790 shares. Based on the indicated price, the tax-related share withholding represented an aggregate value of approximately $96,063, and her remaining holdings are valued at roughly $3.84 million, assuming the same reference price.

Filing Facts

CIK

1583107

Ticker

TBPH

Form

4

Source Type

fda

Accession

0001898490-26-000012

Alert Tier

5